HEADER TRANSFERASE 18-MAY-07 2PZR TITLE CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING TITLE 2 THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: FGFR-2, KERATINOCYTE GROWTH FACTOR RECEPTOR 2, CD332 COMPND 6 ANTIGEN; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR2, BEK, KSAM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYS-S KEYWDS KINASE DOMAIN FOLD CONSISTING OF N- AND C-LOBES, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.CHEN,M.MOHAMMADI REVDAT 6 30-AUG-23 2PZR 1 REMARK REVDAT 5 20-OCT-21 2PZR 1 REMARK SEQADV REVDAT 4 21-DEC-16 2PZR 1 TITLE REVDAT 3 07-MAR-12 2PZR 1 HET HETATM VERSN REVDAT 2 24-FEB-09 2PZR 1 VERSN REVDAT 1 25-SEP-07 2PZR 0 JRNL AUTH H.CHEN,J.MA,W.LI,A.V.ELISEENKOVA,C.XU,T.A.NEUBERT, JRNL AUTH 2 W.T.MILLER,M.MOHAMMADI JRNL TITL A MOLECULAR BRAKE IN THE KINASE HINGE REGION REGULATES THE JRNL TITL 2 ACTIVITY OF RECEPTOR TYROSINE KINASES. JRNL REF MOL.CELL V. 27 717 2007 JRNL REFN ISSN 1097-2765 JRNL PMID 17803937 JRNL DOI 10.1016/J.MOLCEL.2007.06.028 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 15995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 776 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4417 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 49 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.47900 REMARK 3 B22 (A**2) : -2.34600 REMARK 3 B33 (A**2) : -1.13300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : 0.874 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PZR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000042968. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97924 REMARK 200 MONOCHROMATOR : KOHZU DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16398 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11700 REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31400 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2PSQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES PH7.5, 28% PEG 4000, 300MM REMARK 280 (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 53.06850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.32100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 53.06850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.32100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 445 REMARK 465 GLY A 446 REMARK 465 SER A 447 REMARK 465 SER A 448 REMARK 465 HIS A 449 REMARK 465 HIS A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 SER A 455 REMARK 465 GLN A 456 REMARK 465 ASP A 457 REMARK 465 PRO A 458 REMARK 465 MET A 459 REMARK 465 LEU A 460 REMARK 465 ALA A 461 REMARK 465 GLY A 462 REMARK 465 VAL A 463 REMARK 465 SER A 464 REMARK 465 GLU A 465 REMARK 465 TYR A 466 REMARK 465 GLU A 467 REMARK 465 GLY A 488 REMARK 465 GLU A 489 REMARK 465 GLY A 490 REMARK 465 ALA A 491 REMARK 465 PHE A 492 REMARK 465 GLY A 493 REMARK 465 GLY A 583 REMARK 465 MET A 584 REMARK 465 GLU A 585 REMARK 465 TYR A 586 REMARK 465 SER A 587 REMARK 465 TYR A 588 REMARK 465 ASP A 589 REMARK 465 ILE A 590 REMARK 465 ASN A 591 REMARK 465 ARG A 592 REMARK 465 VAL A 593 REMARK 465 PRO A 594 REMARK 465 ASN A 766 REMARK 465 GLU A 767 REMARK 465 GLU A 768 REMARK 465 MET B 445 REMARK 465 GLY B 446 REMARK 465 SER B 447 REMARK 465 SER B 448 REMARK 465 HIS B 449 REMARK 465 HIS B 450 REMARK 465 HIS B 451 REMARK 465 HIS B 452 REMARK 465 HIS B 453 REMARK 465 HIS B 454 REMARK 465 SER B 455 REMARK 465 GLN B 456 REMARK 465 ASP B 457 REMARK 465 PRO B 458 REMARK 465 MET B 459 REMARK 465 LEU B 460 REMARK 465 ALA B 461 REMARK 465 GLY B 462 REMARK 465 VAL B 463 REMARK 465 SER B 464 REMARK 465 GLU B 465 REMARK 465 TYR B 466 REMARK 465 GLY B 488 REMARK 465 GLU B 489 REMARK 465 GLY B 490 REMARK 465 ALA B 491 REMARK 465 PHE B 492 REMARK 465 GLY B 493 REMARK 465 GLY B 583 REMARK 465 MET B 584 REMARK 465 GLU B 585 REMARK 465 TYR B 586 REMARK 465 SER B 587 REMARK 465 TYR B 588 REMARK 465 ASP B 589 REMARK 465 ILE B 590 REMARK 465 ASN B 591 REMARK 465 ARG B 592 REMARK 465 VAL B 593 REMARK 465 PRO B 594 REMARK 465 GLU B 767 REMARK 465 GLU B 768 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 LYS A 485 CG CD CE NZ REMARK 470 LYS A 505 CG CD CE NZ REMARK 470 LYS A 509 CG CD CE NZ REMARK 470 GLU A 510 CG CD OE1 OE2 REMARK 470 LYS A 543 CG CD CE NZ REMARK 470 LYS A 545 CG CD CE NZ REMARK 470 GLU A 595 CG CD OE1 OE2 REMARK 470 GLU A 596 CG CD OE1 OE2 REMARK 470 GLN A 597 CG CD OE1 NE2 REMARK 470 ASN A 727 CG OD1 ND2 REMARK 470 GLU B 467 CG CD OE1 OE2 REMARK 470 LYS B 485 CG CD CE NZ REMARK 470 ASP B 504 CG OD1 OD2 REMARK 470 LYS B 505 CG CD CE NZ REMARK 470 ASP B 506 CG OD1 OD2 REMARK 470 LYS B 507 CG CD CE NZ REMARK 470 LYS B 509 CG CD CE NZ REMARK 470 GLU B 510 CG CD OE1 OE2 REMARK 470 GLU B 595 CG CD OE1 OE2 REMARK 470 GLU B 596 CG CD OE1 OE2 REMARK 470 GLU B 636 CG CD OE1 OE2 REMARK 470 LYS B 658 CG CD CE NZ REMARK 470 LYS B 659 CG CD CE NZ REMARK 470 LYS B 714 CG CD CE NZ REMARK 470 LYS B 717 CG CD CE NZ REMARK 470 ASN B 727 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 469 153.42 -49.28 REMARK 500 PRO A 508 -20.08 -38.93 REMARK 500 ALA A 523 154.78 -49.66 REMARK 500 HIS A 544 141.66 -170.31 REMARK 500 ARG A 579 45.96 -90.67 REMARK 500 GLN A 597 144.29 -30.63 REMARK 500 ARG A 625 -10.35 65.36 REMARK 500 ALA A 628 154.09 178.45 REMARK 500 ASP A 644 80.27 60.99 REMARK 500 LYS A 659 -33.94 -39.91 REMARK 500 ASP A 677 -2.35 -145.56 REMARK 500 PRO B 469 156.54 -49.35 REMARK 500 PRO B 477 105.82 -51.10 REMARK 500 LYS B 505 31.80 -68.36 REMARK 500 ASP B 506 30.11 -149.25 REMARK 500 LYS B 507 44.87 175.84 REMARK 500 PRO B 508 0.98 -45.63 REMARK 500 ASP B 557 70.89 51.42 REMARK 500 ARG B 579 55.80 -102.32 REMARK 500 PRO B 581 127.01 -38.85 REMARK 500 GLN B 597 161.73 -44.96 REMARK 500 LYS B 621 27.79 49.48 REMARK 500 ARG B 625 -22.69 76.09 REMARK 500 ALA B 643 -169.42 -124.12 REMARK 500 ASP B 644 72.92 57.57 REMARK 500 ASN B 653 54.09 -96.13 REMARK 500 TYR B 657 -6.36 85.64 REMARK 500 ASN B 662 18.17 56.78 REMARK 500 TYR B 704 64.84 37.81 REMARK 500 ASN B 727 44.80 71.09 REMARK 500 TRP B 740 36.86 -93.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 ACP A 803 REMARK 610 ACP B 803 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACP A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACP B 803 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PSQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF REMARK 900 RECEPTOR 2 (FGFR2) KINASE DOMAIN REMARK 900 RELATED ID: 2PVF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED WILD TYPE REMARK 900 FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND REMARK 900 SUBSTRATE PEPTIDE REMARK 900 RELATED ID: 2PVY RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED REMARK 900 CRANIOSYNOSTOSIS SYNDROME. REMARK 900 RELATED ID: 2PWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME. REMARK 900 RELATED ID: 2PY3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME REMARK 900 RELATED ID: 2PZ5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME REMARK 900 RELATED ID: 2PZP RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME REMARK 900 RELATED ID: 2Q0B RELATED DB: PDB REMARK 900 CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING REMARK 900 THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME DBREF 2PZR A 458 768 UNP P21802 FGFR2_HUMAN 458 768 DBREF 2PZR B 458 768 UNP P21802 FGFR2_HUMAN 458 768 SEQADV 2PZR MET A 445 UNP P21802 EXPRESSION TAG SEQADV 2PZR GLY A 446 UNP P21802 EXPRESSION TAG SEQADV 2PZR SER A 447 UNP P21802 EXPRESSION TAG SEQADV 2PZR SER A 448 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS A 449 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS A 450 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS A 451 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS A 452 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS A 453 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS A 454 UNP P21802 EXPRESSION TAG SEQADV 2PZR SER A 455 UNP P21802 EXPRESSION TAG SEQADV 2PZR GLN A 456 UNP P21802 EXPRESSION TAG SEQADV 2PZR ASP A 457 UNP P21802 EXPRESSION TAG SEQADV 2PZR ALA A 491 UNP P21802 CYS 491 ENGINEERED MUTATION SEQADV 2PZR ARG A 641 UNP P21802 LYS 641 ENGINEERED MUTATION SEQADV 2PZR MET B 445 UNP P21802 EXPRESSION TAG SEQADV 2PZR GLY B 446 UNP P21802 EXPRESSION TAG SEQADV 2PZR SER B 447 UNP P21802 EXPRESSION TAG SEQADV 2PZR SER B 448 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS B 449 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS B 450 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS B 451 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS B 452 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS B 453 UNP P21802 EXPRESSION TAG SEQADV 2PZR HIS B 454 UNP P21802 EXPRESSION TAG SEQADV 2PZR SER B 455 UNP P21802 EXPRESSION TAG SEQADV 2PZR GLN B 456 UNP P21802 EXPRESSION TAG SEQADV 2PZR ASP B 457 UNP P21802 EXPRESSION TAG SEQADV 2PZR ALA B 491 UNP P21802 CYS 491 ENGINEERED MUTATION SEQADV 2PZR ARG B 641 UNP P21802 LYS 641 ENGINEERED MUTATION SEQRES 1 A 324 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 324 PRO MET LEU ALA GLY VAL SER GLU TYR GLU LEU PRO GLU SEQRES 3 A 324 ASP PRO LYS TRP GLU PHE PRO ARG ASP LYS LEU THR LEU SEQRES 4 A 324 GLY LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL SEQRES 5 A 324 MET ALA GLU ALA VAL GLY ILE ASP LYS ASP LYS PRO LYS SEQRES 6 A 324 GLU ALA VAL THR VAL ALA VAL LYS MET LEU LYS ASP ASP SEQRES 7 A 324 ALA THR GLU LYS ASP LEU SER ASP LEU VAL SER GLU MET SEQRES 8 A 324 GLU MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE SEQRES 9 A 324 ASN LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR SEQRES 10 A 324 VAL ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU SEQRES 11 A 324 TYR LEU ARG ALA ARG ARG PRO PRO GLY MET GLU TYR SER SEQRES 12 A 324 TYR ASP ILE ASN ARG VAL PRO GLU GLU GLN MET THR PHE SEQRES 13 A 324 LYS ASP LEU VAL SER CYS THR TYR GLN LEU ALA ARG GLY SEQRES 14 A 324 MET GLU TYR LEU ALA SER GLN LYS CYS ILE HIS ARG ASP SEQRES 15 A 324 LEU ALA ALA ARG ASN VAL LEU VAL THR GLU ASN ASN VAL SEQRES 16 A 324 MET ARG ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE ASN SEQRES 17 A 324 ASN ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU SEQRES 18 A 324 PRO VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG SEQRES 19 A 324 VAL TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL SEQRES 20 A 324 LEU MET TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR SEQRES 21 A 324 PRO GLY ILE PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS SEQRES 22 A 324 GLU GLY HIS ARG MET ASP LYS PRO ALA ASN CYS THR ASN SEQRES 23 A 324 GLU LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL SEQRES 24 A 324 PRO SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP SEQRES 25 A 324 LEU ASP ARG ILE LEU THR LEU THR THR ASN GLU GLU SEQRES 1 B 324 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 B 324 PRO MET LEU ALA GLY VAL SER GLU TYR GLU LEU PRO GLU SEQRES 3 B 324 ASP PRO LYS TRP GLU PHE PRO ARG ASP LYS LEU THR LEU SEQRES 4 B 324 GLY LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL SEQRES 5 B 324 MET ALA GLU ALA VAL GLY ILE ASP LYS ASP LYS PRO LYS SEQRES 6 B 324 GLU ALA VAL THR VAL ALA VAL LYS MET LEU LYS ASP ASP SEQRES 7 B 324 ALA THR GLU LYS ASP LEU SER ASP LEU VAL SER GLU MET SEQRES 8 B 324 GLU MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE SEQRES 9 B 324 ASN LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR SEQRES 10 B 324 VAL ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU SEQRES 11 B 324 TYR LEU ARG ALA ARG ARG PRO PRO GLY MET GLU TYR SER SEQRES 12 B 324 TYR ASP ILE ASN ARG VAL PRO GLU GLU GLN MET THR PHE SEQRES 13 B 324 LYS ASP LEU VAL SER CYS THR TYR GLN LEU ALA ARG GLY SEQRES 14 B 324 MET GLU TYR LEU ALA SER GLN LYS CYS ILE HIS ARG ASP SEQRES 15 B 324 LEU ALA ALA ARG ASN VAL LEU VAL THR GLU ASN ASN VAL SEQRES 16 B 324 MET ARG ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE ASN SEQRES 17 B 324 ASN ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU SEQRES 18 B 324 PRO VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG SEQRES 19 B 324 VAL TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL SEQRES 20 B 324 LEU MET TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR SEQRES 21 B 324 PRO GLY ILE PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS SEQRES 22 B 324 GLU GLY HIS ARG MET ASP LYS PRO ALA ASN CYS THR ASN SEQRES 23 B 324 GLU LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL SEQRES 24 B 324 PRO SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP SEQRES 25 B 324 LEU ASP ARG ILE LEU THR LEU THR THR ASN GLU GLU HET SO4 A 801 5 HET SO4 A 802 5 HET ACP A 803 10 HET SO4 B 801 5 HET SO4 B 802 5 HET ACP B 803 10 HETNAM SO4 SULFATE ION HETNAM ACP PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER HETSYN ACP ADENOSINE-5'-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE FORMUL 3 SO4 4(O4 S 2-) FORMUL 5 ACP 2(C11 H18 N5 O12 P3) FORMUL 9 HOH *49(H2 O) HELIX 1 1 PRO A 477 ASP A 479 5 3 HELIX 2 2 THR A 524 ILE A 541 1 18 HELIX 3 3 ASN A 571 ARG A 579 1 9 HELIX 4 4 THR A 599 GLN A 620 1 22 HELIX 5 5 ALA A 628 ARG A 630 5 3 HELIX 6 6 PRO A 666 ALA A 671 5 6 HELIX 7 7 PRO A 672 ASP A 677 1 6 HELIX 8 8 THR A 681 PHE A 697 1 17 HELIX 9 9 PRO A 708 GLU A 710 5 3 HELIX 10 10 GLU A 711 GLU A 718 1 8 HELIX 11 11 THR A 729 TRP A 740 1 12 HELIX 12 12 VAL A 743 ARG A 747 5 5 HELIX 13 13 THR A 749 THR A 765 1 17 HELIX 14 14 PRO B 477 ASP B 479 5 3 HELIX 15 15 THR B 524 ILE B 541 1 18 HELIX 16 16 ASN B 571 ARG B 579 1 9 HELIX 17 17 THR B 599 GLN B 620 1 22 HELIX 18 18 ALA B 628 ARG B 630 5 3 HELIX 19 19 ALA B 671 ASP B 677 1 7 HELIX 20 20 THR B 681 THR B 698 1 18 HELIX 21 21 PRO B 708 GLU B 718 1 11 HELIX 22 22 THR B 729 TRP B 740 1 12 HELIX 23 23 VAL B 743 ARG B 747 5 5 HELIX 24 24 THR B 749 THR B 765 1 17 SHEET 1 A 5 LEU A 481 PRO A 486 0 SHEET 2 A 5 VAL A 495 VAL A 501 -1 O MET A 497 N LYS A 485 SHEET 3 A 5 ALA A 511 LYS A 517 -1 O VAL A 512 N ALA A 500 SHEET 4 A 5 TYR A 561 VAL A 564 -1 O VAL A 564 N ALA A 515 SHEET 5 A 5 LEU A 550 CYS A 554 -1 N LEU A 551 O ILE A 563 SHEET 1 B 2 CYS A 622 ILE A 623 0 SHEET 2 B 2 ARG A 649 ASP A 650 -1 O ARG A 649 N ILE A 623 SHEET 1 C 2 VAL A 632 VAL A 634 0 SHEET 2 C 2 MET A 640 ILE A 642 -1 O ARG A 641 N LEU A 633 SHEET 1 D 5 LEU B 481 PRO B 486 0 SHEET 2 D 5 VAL B 495 VAL B 501 -1 O MET B 497 N LYS B 485 SHEET 3 D 5 ALA B 511 LYS B 517 -1 O VAL B 516 N VAL B 496 SHEET 4 D 5 TYR B 561 GLU B 565 -1 O VAL B 564 N ALA B 515 SHEET 5 D 5 LEU B 550 CYS B 554 -1 N LEU B 551 O ILE B 563 SHEET 1 E 2 CYS B 622 ILE B 623 0 SHEET 2 E 2 ARG B 649 ASP B 650 -1 O ARG B 649 N ILE B 623 SHEET 1 F 2 VAL B 632 VAL B 634 0 SHEET 2 F 2 MET B 640 ILE B 642 -1 O ARG B 641 N LEU B 633 SITE 1 AC1 4 ARG A 625 LEU A 647 ARG A 649 ARG A 664 SITE 1 AC2 4 ARG A 737 VAL B 743 PRO B 744 SER B 745 SITE 1 AC3 5 VAL A 495 ALA A 515 GLU A 565 ALA A 567 SITE 2 AC3 5 LEU A 633 SITE 1 AC4 3 ARG B 625 ARG B 649 ARG B 664 SITE 1 AC5 2 THR B 729 ASN B 730 SITE 1 AC6 6 LEU B 487 ALA B 515 GLU B 565 TYR B 566 SITE 2 AC6 6 ALA B 567 LEU B 633 CRYST1 106.137 116.642 63.636 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009422 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008573 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015714 0.00000